Loading…
Back To Schedule
Monday, September 19 • 9:15am - 9:45am
Partner Keynote: Innovations in BioManufacturing, a CDMO perspective

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
  • This year marks the 40th year of the approval of the first FDA approve biotechnology drug. Our industry has evolved tremendously and we have seen incredible changes to make life impacting medicines available.
  • We have seen an evolution and expansion in the modalities that are going through the drug development life cycle. Biomanufacturing needs to be ready with the required infrastructure, innovation, flexibility and expertise to deliver these treatments.
  • CDMOs, such as FUJIFILM Diosynth Biotechnologies, are implementing innovations that will drive the future of Biomanufacturing. Innovation in the CDMO spaces, can be different than innovation from discovery and molecule ownership and will bring different value.
Speakers
avatar for Christine E. Vannais

Christine E. Vannais

Chief Operating Officer, FUJIFILM Diosynth Biotechnologies
Christine Vannais is a seasoned professional with over twenty years of experience working in a variety of industries including contract biopharmaceutical development and manufacturing, USDA biological vaccine manufacturing and research, FDA and EU small molecule manufacturing, primary... Read More →

Monday September 19, 2022 9:15am - 9:45am EDT
  General Session